Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Relationship between body mass index and alanine aminotransferase concentration in non-diabetic Korean adults

Abstract

Background/Objectives:

Obesity has been identified as an important factor of elevated alanine aminotransferase (ALT), a surrogate of non-alcoholic fatty liver disease. We investigated the relationship between obesity and elevated ALT in the general Korean population.

Subjects/Methods:

The study sample was comprised of 3098 Korean adults who had participated in the 2005 Korean National Health and Nutrition Examination Survey. Obesity was assessed using body mass index (BMI). Overweight (23BMI<25) and obese (BMI25) were defined by the International Obesity Task Force for Asian adults. ALT was measured by enzymatic methods. Elevated ALT was defined as an enzyme activity >40 IU/l for men and >31 IU/l for women.

Results:

Among participants, 246 (12.7%) men and 86 (7.4%) women displayed elevated ALT. BMI was significantly higher in men and women with elevated ALT than those with normal ALT (P<0.0001). The unadjusted odds ratio (OR) for elevated ALT increased according to the degree of BMI in men (OR: 1.9, 95% confidence interval (CI): 1.25–2.93 in overweight vs OR: 5.01, 95% CI: 3.49–7.21 in obese; P<0.0001) and women (OR: 2.44, 95% CI: 1.24–4.82 vs OR: 3.94, 95% CI: 2.18–7.13; P<0.0001). This trend did not differ after adjustment for putative risk factors including alcohol intake in men (OR: 1.56 vs OR: 3.47, P<0.0001) and women (OR: 1.55 vs OR: 3.10, P=0.0015).

Conclusion:

BMI is implicated as a strong risk factor of elevated ALT in non-diabetic Korean adults.

Introduction

Chronic liver disease is a worldwide health problem (Clark et al., 2003; Chen et al., 2007). The major causes of chronic liver disease include non-alcoholic fatty liver disease (NAFLD), hepatitis B or C, and excessive alcohol consumption (Pendino et al., 2005; Chen et al., 2006). NAFLD represents a spectrum of diseases that range from simple fatty liver (or steatosis), a generally benign accumulation of triglyceride (TG) in hepatocytes, to non-alcoholic steatohepatitis, which can progress to chronic liver disease, cirrhosis, and hepatocellular carcinoma (Teli et al., 1995; Clark et al., 2002; Saito et al., 2007). Currently, NAFLD is considered to be the most common cause of liver disease (Daniel et al., 1999).

Individuals with NAFLD are commonly characterized by elevated circulating concentrations of liver enzymes including alanine aminotransferase (ALT), aspartate aminotransferase, and γ-glutamyltransferase (Clark et al., 2003). Of these liver enzymes, ALT is most closely related to liver fat accumulation (Schindhelm et al., 2006), and, thus, it has been used as a surrogate marker of NAFLD in epidemiologic studies (Hanley et al., 2005; Wannamethee et al., 2005; Chang et al., 2007). Less well known, however, are the risk factors for elevated ALT concentration that influence the prevalence and etiology of NAFLD.

Cross-sectional studies from Western countries have reported alcohol intake to be strongly associated with increased ALT levels (Ruhl and Everhart, 2005; Ioannou et al., 2006). However, other studies did not confirm such a relationship between alcohol intake and ALT level (Nakamura et al., 1998; Adams et al., 2008). Obesity has also been identified as a risk factor strongly associated with elevated ALT concentration (Ruhl and Everhart, 2003; Adams et al., 2008; Kim et al., 2008). It is perhaps not surprising that NAFLD is frequently observed in obese people. As obesity is dramatically increasing in both Asian and Western populations, it is likely that obesity will become an increasingly important risk factor for elevated ALT concentration (Flegal et al., 2002; Thorburn, 2005; Ko et al., 2007; Pan et al., 2008).

In Korea, three studies on the relationship between obesity and elevated ALT concentration have been reported (Lee et al., 2001; Sung et al., 2007; Song et al., 2008). However, these studies were limited to specific groups of Korean subjects; one study used only men (Lee et al., 2001), whereas the other involved only obese women who had visited the hospital for the management of their obesity (Song et al., 2008). Further limiting the value of these studies was their failure to consider alcohol intake, which is a potential risk factor of elevated ALT concentration (Lee et al., 2001; Sung et al., 2007).

In this study, we re-examined the relationship between obesity and elevated ALT concentration after adjusting for several putative risk factors including alcohol intake using the most recent survey data from the largest, nationally representative, general Korean population available.

Materials and methods

Subjects

The study was based on the third Korean National Health and Nutrition Examination Survey (KNHANES III), a cross-sectional and nationally representative survey carried out by the Korea Centers for Disease Control and Prevention from April to June 2005. The survey used a stratified multistage probability sampling design. KNHANES III consisted of surveys of health interview, health behavior, and nutrition, as well as a health examination study. Of the 7597 Koreans who participated in the health examination study, 5565 adults 20+ years of age were selected for this study. Pregnant or lactating women were excluded. Other exclusion criteria were diabetes (fasting plasma glucose (FPG) 126 mg per 100 ml or hypoglycemic agent or insulin administration) or history of diabetes, cancer, thyroid disease, another liver disease such as chronic hepatitis or positive serum hepatitis B surface antigen, and active intake of weight loss preparations. In particular, among 5565 adults (+20 years of age) who were selected for this study, 222 adults (4%) had positive serum hepatitis B surface antigen. From the remaining 3141 subjects, 43 were further excluded because they had insufficient information on anthropometric measurement or ALT concentration. A total of 3098 Korean adults (1931 men, 1167 women; mean age, 51.2±15.8 years) were ultimately eligible for the analysis. Informed written consent for participation was obtained from each individual. The study was approved by the Korea Centers for Disease Control and Prevention Institutional Review Board.

Body composition measurements

Height, body weight, and waist circumference (WC) were measured as part of the health examination study. Height and body weight were measured while the subjects were wearing light clothes without shoes. WC was measured to the nearest 0.1 cm at the narrowest point between the lowest rib and the uppermost lateral border of the right iliac crest. Body mass index (BMI) was calculated from the measured height and weight of participants. The cutoff points of overweight and obesity were defined by the International Obesity Task Force for Asian adults in the Asian and Pacific regions (World Health Organization, 2000). We classified subjects into three categories: normal and underweight (<23 kg/m2), overweight (23 and <25 kg/m2), and obese (25 kg/m2) based on the BMI. Abdominal obesity was defined by WC 90 cm for men or 80 cm for women (Alberti et al., 2005).

Alcohol consumption

Alcohol intake was assessed by questionnaires about drinking behavior during the month before the interview. The subjects were asked about their average frequency (days in month) and amount (in milliliters) of alcoholic beverages ingested on a typical occasion or during a typical day. The average amount of alcoholic beverage consumed was converted into the amount of pure alcohol (in g) consumed per day. Alcohol intake was used to categorized participants into three groups: non-drink, light, or moderate drinker (1–30 g alcohol/day), and heavy drinker (30 g alcohol/day) (Song et al., 2008).

Metabolic variable measurements

Blood samples for measurements of TG, high-density lipoprotein cholesterol (HDL-C), and FPG and ALT were collected after an overnight fast. All biochemical analyses were carried out within 2 h of blood sampling. TG, HDL-C, FPG, and ALT were measured by enzymatic methods with an ADVIA 1650 autoanalyzer (Bayer, USA). Hepatitis B surface antigen was measured by an electrochemiluminescence immunoassay (Roche, Germany) (Van Helden et al., 2004). Elevated ALT was defined as an enzyme activity >40 IU/l for men and >31 for women (Clark et al., 2003; Ioannou et al., 2006). Blood pressure was measured with a Baumannomete mercury sphygmomanometer (WA Baum, NY, USA) after the subjects had rested for 5 min in a sitting position. Systolic (SBP) and diastolic blood pressures (DBP) were measured at phase I and V Korotkoff sound (The American Society of Hypertension, 1992), respectively. Three readings of SBP and DBP were recorded, and the average of the last two readings was used for data analysis. The cutoff points for abnormal FPG, dyslipidemia and elevated blood pressure were defined by the criteria of the National Cholesterol Education Program Adult Treatment Panel III (NCEP, 2001): (1) FPG6.11 mmol/l (110 mg per 100 ml), (2) TG1.70 mmol/l (150 mg per 100 ml), (3) HDL-C<1.03 mmol/l (40 mg per 100 ml) for men or 1.29 mmol/l (50 mg per 100 ml) for women, and (4) SBP120 or DBP80 mm Hg.

Statistical analyses

Data are expressed as number and percentage (categorical), or mean±s.d. (continuous). Differences between normal subjects and those with elevated ALT were evaluated using Student's t-test or χ2 test, as appropriate. Differences among the three BMI groups were determined using generalized linear model (Duncan's test of multiple comparisons). Multivariable-adjusted logistic regression analysis was conducted to examine the odds ratio (OR) and 95% confidence interval (CI) for the elevated ALT across a range of BMI or other potential risk factors. Statistical analyses were performed with SAS software version 9.1 (SAS Institute, Cary, NC, USA). Statistical significance was defined as P<0.05.

Results

Characteristics of study subjects

Of 3098 Korean adults assessed, 246 (12.7%) men and 86 (7.4%) women displayed elevated ALT (Table 1). Men with elevated ALT tended to be younger than those with normal ALT; this trend was not evident for women. BMI and WC were significantly higher in men and women with elevated ALT (P<0.0001). The prevalence of heavy alcohol consumption seemed to be higher in men with elevated ALT than in men with normal ALT (P=0.0508), but this trend was not seen in women. Men with elevated ALT displayed higher FPG, TG, SBP, and DBP, and lower HDL-C. In women, FPG, TG, and DBP were significantly higher in subjects with elevated ALT than in subjects with a normal ALT level.

Table 1 Characteristics of study subjects

Characteristics of subjects according to the degree of BMI

BMI and WC increased significantly at each category of BMI (P<0.0001) (Table 2). ALT concentration significantly increased according to the degree of BMI in both men and women (P<0.0001). As expected, the prevalence of subjects with elevated ALT was significantly higher in overweight and obese subjects than in normal weight adults of both genders (P<0.0001). The influence of alcohol intake was not appreciably different among the three BMI groups for both genders. Metabolic variables such as FPG, TG, and blood pressure were significantly increased on increasing BMI in both genders (P<0.0001). HDL-C was also significantly decreased by increased BMI.

Table 2 Characteristics of subjects according to BMI

ORs and CIs for elevated ALT concentration across the range of BMI

Table 3 shows the results of logistic regression analysis to determine ORs for elevated ALT level according to BMI. The unadjusted OR for elevated ALT significantly increased in overweight men (OR: 1.92, 95% CI: 1.25–2.93). The unadjusted OR for elevated ALT increased according to the increase of BMI (OR: 1.92, 95% CI: 1.25–2.93 vs OR: 5.01, 95% CI: 3.49–7.21; P<0.0001) in men. In women, the unadjusted OR for elevated ALT consistently was significantly increased according to degree of BMI (OR: 2.44, 95% CI: 1.24–4.82 vs OR: 3.94, 95% CI: 2.18–7.13; P<0.0001). This trend did not differ after adjustment for age, alcohol intake, and metabolic variables such as FPG, TG, HDL-C, and blood pressure in both men (OR: 1.56 vs OR: 3.47, P<0.0001) and women (OR: 1.55 vs OR: 3.10, P=0.0015).

Table 3 Odds ratios (95% confidence intervals) for elevated ALT concentrations across the range of BMIs

Multiple logistic regression analysis of other potential risk factors and their association with elevated ALT concentration

Table 4 shows the OR and 95% CIs for the individual risk factors associated with elevated ALT among Korean adults. In the multiple logistic regression analysis, we found that the potential risk factors for the elevated ALT concentration were age, WC (90 cm for men and 80 cm for women), and TG1.70 mmol/l (150 mg per 100 ml) after adjusted for age, BMI, alcohol intake, FPG, TG, and HDL-C in men. In women, however, none of these factors were significant.

Table 4 Multiple logistic analyses of other potential risk factors and their association with elevated ALT

Discussion

Obesity has been reported as a risk factor associated with elevation of ALT, which is a surrogate marker of NAFLD (Robinson and Whitehead, 1989; Salvaggio et al., 1991; Bizzaro et al., 1992; Chen et al., 2007). We evaluated the relationship between obesity and an elevated ALT concentration among general Korean population based on the data from the 2005 KNHANES survey. In this large, nationally representative, population-based study, we found that BMI had a strong relationship with an elevated ALT concentration in non-diabetic Korean adults. The prevalence of the elevated ALT significantly increased in overweight (23BMI<25) and obese (BMI25) subjects compared with subjects with normal weight. The risk of elevated ALT levels was over threefold higher in obese Korean adults than Korean adults with normal weight after adjustment for other risk factors such as age, alcohol intake, and several metabolic variables in both genders. The risk for elevated ALT concentration tended to increase according to the severity of obesity. These results suggest that overall obesity measured by BMI is an independent indicator of elevated ALT concentration among non-diabetic Korean population.

An earlier study showed that among Australians aged 20–80 years, overweight (25BMI<30) and obese (BMI30) subjects had a two–threefold and sevenfold increased risk for the elevation of ALT, respectively, after adjusting for age and alcohol consumption compared with subjects with normal weight (Adams et al., 2008). Similarly, NHANES III data has revealed that the risk of elevated ALT activity is also two–threefold higher in overweight (25BMI<30) and obese (BMI30) American adults compared with adults with normal weight after adjustment for age, sex, ethnicity, alcohol, smoking, caffeine consumption, and HgbA1c (Ruhl and Everhart, 2005). The results from these two studies substantially agree with our study. However, a direct comparison of these studies is not possible because of different conditions used, principally the differing BMI definitions for Asians and Caucasians.

Although BMI, WC, and abdominal height were all highly correlated with ALT levels among subjects aged 35–80 years from a study conducted in Western New York (Stranges et al., 2004), central obesity assessed by abdominal height was reported to be a better correlate of ALT levels than BMI after adjusting for several covariates in the analysis of multiple linear regression in both sexes. A cross-sectional study using non-diabetic overweight Korean women documented that visceral fat was the strongest predictor of elevated ALT concentration among the anthropometric variables including BMI (Song et al., 2008). This earlier study showed that the adjusted OR for elevation of ALT increased by threefold in third quartile (102.7–135 cm2) of visceral adipose tissue and up to 15-fold in the highest quartile (135.1–382.7 cm2) after adjustment for age, alcohol consumption, and several metabolic variables. From this result, we also tested whether abdominal obesity as measured by WC was a better correlate of ALT levels than BMI. We found that WC tended to significantly increase the risk of elevated ALT in men (OR: 2.44, 95% CI: 1.73–3.43), but not in women (OR: 1.83, 95% CI: 0.97–3.46) suggesting that BMI may be a stronger indicator of elevated ALT concentration than WC in the general Korean population.

The data from NHANES conducted between 1998 and 2002 showed that alcohol consumption is a strong predictor of elevated ALT activity (Ioannou et al., 2006). However, in our study, alcohol intake was not significantly associated with the risk for elevated ALT in both Korean men and women. Similarly, the Western New York Health Study indicated that obesity and body fat distribution may be more important than alcohol consumption for high ALT concentration (Stranges et al., 2004). Among Australian adults, obesity accounted for half of the abnormal ALT levels in the study subjects, whereas excessive alcohol intake was responsible for <10% suggesting that excess weight is a greater risk factor of ALT levels than excessive alcohol consumption (Adams et al., 2008). In a 4-year follow-up study using Korean male workers aged 25–50 years, being overweight increased the risk of elevated ALT by 5–14-fold, but alcohol consumption was not related to ALT levels when adjusted for age, smoking, and exercise (Lee et al., 2001), which is consistent with the present finding. Studies conducted with Japanese adults have also reported that alcohol consumption was not significantly related to ALT (Nakamura, 1980; Nakamura et al., 1998).

Our study has several limitations. As our results are based on a cross-sectional design, we could not define the causal relationship between obesity and an elevated ALT concentration. Secondly, we did not measure hepatitis C antibody, which is known to be related to an elevated ALT. However, the prevalence of hepatitis C virus-related chronic liver disease is low among Korean adults (Kwon and Bae, 2008). Third, we used an elevated ALT concentration as a surrogate marker of liver damage instead of liver biopsy, which is the standard way to diagnose NAFLD (Hultcrantz et al., 1986; Ratziu et al., 2000; Skelly et al., 2001). Thus, our findings cannot, with confidence, be used to claim a direct relationship between obesity and NAFLD in the general Korean population. The definitive means to establish a direct relationship, liver biopsy, cannot ethically be used in a large population study.

Conclusions

Obesity defined by BMI is presently strongly associated with an elevation of ALT concentration, as a surrogate of NAFLD, in non-diabetic Korean adults. However, in an attempt to evaluate the causal relationship between obesity and an elevated ALT concentration, large-scale follow-up studies should be conducted.

Conflict of interest

The authors declare no conflict of interest.

References

  • Adams LA, Knuiman MW, Divitini ML, Olynyk JK (2008). Body mass index is a stronger predictor of alanine aminotransaminase levels than alcohol consumption. J Gastroenterol Hepatol 23, 1089–1093.

    CAS  Article  Google Scholar 

  • Alberti KG, Zimmet P, Shaw J (2005). The metabolic syndrome—a new worldwide definition. Lancet 366, 1059–1062.

    Article  Google Scholar 

  • Bizzaro N, Tremolada F, Casarin C, Bonetti P, Noventa F, Diodati G et al. (1992). Serum alanine aminotransferase levels among volunteer blood donors: effect of sex, alcohol intake and obesity. Ital J Gastroenterol 24, 237–241.

    CAS  PubMed  Google Scholar 

  • Chang Y, Ryu S, Sung E, Jang Y (2007). Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease. Clin Chem 53, 686–692.

    CAS  Article  Google Scholar 

  • Chen CH, Huang MH, Yang JC, Nien CK, Yang CC, Yeh YH et al. (2006). Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of Taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults. J Clin Gastroenterol 40, 745–752.

    CAS  Article  Google Scholar 

  • Chen CH, Huang MH, Yang JC, Nien CK, Yang CC, Yeh YH et al. (2007). Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan. J Gastroenterol Hepatol 22, 1482–1489.

    CAS  Article  Google Scholar 

  • Clark JM, Brancati FL, Diehl AM (2002). Nonalcoholic fatty liver disease. Gastroenterology 122, 1649–1657.

    Article  Google Scholar 

  • Clark JM, Brancati FL, Diehl AM (2003). The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 98, 960–967.

    CAS  Article  Google Scholar 

  • Daniel S, Ben-Menachem T, Vasudevan G, Ma CK, Blumenkehl M (1999). Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients. Am J Gastroenterol 94, 3010–3014.

    CAS  Article  Google Scholar 

  • Flegal KM, Carroll MD, Ogden CL, Johnson CL (2002). Prevalence and trends in obesity among US adults, 1999–2000. JAMA 288, 1723–1727.

    Article  Google Scholar 

  • Hanley AJ, Williams K, Festa A, Wagenknecht LE, D’Agostino Jr RB, Haffner SM (2005). Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study. Diabetes 54, 3140–3147.

    CAS  Article  Google Scholar 

  • Hultcrantz R, Glaumann H, Lindberg G, Nilsson LH (1986). Liver investigation in 149 asymptomatic patients with moderately elevated activities of serum aminotransferases. Scand J Gastroenterol 21, 109–113.

    CAS  Article  Google Scholar 

  • Ioannou GN, Boyko EJ, Lee SP (2006). The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999–2002. Am J Gastroenterol 101, 76–82.

    Article  Google Scholar 

  • Kim IK, Kim J, Kang JH, Song J (2008). Serum leptin as a predictor of fatty liver in 7-year-old Korean children. Ann Nutr Metab 53, 109–116.

    CAS  Article  Google Scholar 

  • Ko TC, Chan J, Chan A, Wong P, Hui S, Chow F et al. (2007). Doubling over ten years of central obesity in Hong Kong Chinese working men. Chin Med J (Engl) 120, 1151–1154.

    Article  Google Scholar 

  • Kwon JH, Bae SH (2008). Current status and clinical course of hepatitis C virus in Korea. Korean J Gastroenterol 51, 360–367.

    PubMed  Google Scholar 

  • Lee DH, Ha MH, Christiani DC (2001). Body weight, alcohol consumption and liver enzyme activity—a 4-year follow-up study. Int J Epidemiol 30, 766–770.

    CAS  Article  Google Scholar 

  • Nakamura K, Motohashi Y, Kikuchi S, Tanaka M, Nakano S (1998). Liver transferase activity in healthy Japanese employees aged 18–39 years. Ind Health 36, 218–222.

    CAS  Article  Google Scholar 

  • Nakamura S (1980). Alcohol, liver function tests, and high density lipoprotein cholesterol in university students. Tohoku J Exp Med 132, 241–242.

    CAS  Article  Google Scholar 

  • NCEP (2001). Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285, 2486–2497.

    Article  Google Scholar 

  • Pan WH, Lee MS, Chuang SY, Lin YC, Fu ML (2008). Obesity pandemic, correlated factors and guidelines to define, screen and manage obesity in Taiwan. Obes Rev 9 (Suppl 1), 22–31.

    Article  Google Scholar 

  • Pendino GM, Mariano A, Surace P, Caserta CA, Fiorillo MT, Amante A et al. (2005). Prevalence and etiology of altered liver tests: a population-based survey in a Mediterranean town. Hepatology 41, 1151–1159.

    Article  Google Scholar 

  • Ratziu V, Giral P, Charlotte F, Bruckert E, Thibault V, Theodorou I et al. (2000). Liver fibrosis in overweight patients. Gastroenterology 118, 1117–1123.

    CAS  Article  Google Scholar 

  • Robinson D, Whitehead TP (1989). Effect of body mass and other factors on serum liver enzyme levels in men attending for well population screening. Ann Clin Biochem 26 (Part 5), 393–400.

    Article  Google Scholar 

  • Ruhl CE, Everhart JE (2003). Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. Gastroenterology 124, 71–79.

    CAS  Article  Google Scholar 

  • Ruhl CE, Everhart JE (2005). Joint effects of body weight and alcohol on elevated serum alanine aminotransferase in the United States population. Clin Gastroenterol Hepatol 3, 1260–1268.

    CAS  Article  Google Scholar 

  • Saito T, Misawa K, Kawata S (2007). 1. Fatty liver and non-alcoholic steatohepatitis. Intern Med 46, 101–103.

    Article  Google Scholar 

  • Salvaggio A, Periti M, Miano L, Tavanelli M, Marzorati D (1991). Body mass index and liver enzyme activity in serum. Clin Chem 37, 720–723.

    CAS  PubMed  Google Scholar 

  • Schindhelm RK, Diamant M, Dekker JM, Tushuizen ME, Teerlink T, Heine RJ (2006). Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease. Diabetes Metab Res Rev 22, 437–443.

    CAS  Article  Google Scholar 

  • Skelly MM, James PD, Ryder SD (2001). Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology. J Hepatol 35, 195–199.

    CAS  Article  Google Scholar 

  • Song HR, Yun KE, Park HS (2008). Relation between alanine aminotransferase concentrations and visceral fat accumulation among nondiabetic overweight Korean women. Am J Clin Nutr 88, 16–21.

    CAS  Article  Google Scholar 

  • Stranges S, Dorn JM, Muti P, Freudenheim JL, Farinaro E, Russell M et al. (2004). Body fat distribution, relative weight, and liver enzyme levels: a population-based study. Hepatology 39, 754–763.

    Article  Google Scholar 

  • Sung KC, Ryan MC, Kim BS, Cho YK, Kim BI, Reaven GM (2007). Relationships between estimates of adiposity, insulin resistance, and nonalcoholic fatty liver disease in a large group of nondiabetic Korean adults. Diabetes Care 30, 2113–2118.

    CAS  Article  Google Scholar 

  • Teli MR, James OF, Burt AD, Bennett MK, Day CP (1995). The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology 22, 1714–1719.

    CAS  Article  Google Scholar 

  • The American Society of Hypertension (1992). Recommendations for routine blood pressure measurement by indirect cuff sphygmomanometry. American Society of Hypertension. Am J Hypertens 5, 207–209.

    Article  Google Scholar 

  • Thorburn AW (2005). Prevalence of obesity in Australia. Obes Rev 6, 187–189.

    CAS  Article  Google Scholar 

  • Van Helden J, Denoyel G, Karwowska S, Reamer R, Schmalz J, Wright T et al. (2004). Performance of hepatitis B assays on the Bayer ADVIA Centaur Immunoassay System. Clin Lab 50, 63–73.

    CAS  PubMed  Google Scholar 

  • Wannamethee SG, Shaper AG, Lennon L, Whincup PH (2005). Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men. Diabetes Care 28, 2913–2918.

    CAS  Article  Google Scholar 

  • World Health Organization (2000). The Asia-Pacific Perspective: Redefining Obesity and Its Treatment. IOTF, Health Communications Australia Pty Ltd.: Brisbane.

Download references

Acknowledgements

This research was supported by grant from Dong-il Culture Scholarship Foundation in 2009.

Author information

Affiliations

Authors

Corresponding author

Correspondence to I Jo.

Additional information

Contributors: JK contributed to analysis and interpretation of data and manuscript preparation, and IJ is responsible for all the process of this study.

Author contributions: JK contributed to analysis and interpretation of data and manuscript preparation, and IJ is responsible for all the process of this study.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Kim, J., Jo, I. Relationship between body mass index and alanine aminotransferase concentration in non-diabetic Korean adults. Eur J Clin Nutr 64, 169–175 (2010). https://doi.org/10.1038/ejcn.2009.131

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ejcn.2009.131

Keywords

  • obesity
  • alanine aminotransferase
  • non-alcoholic fatty liver disease
  • Korean adults

Further reading

Search

Quick links